Karus Therapeutics' Unattributed VC Round

Karus Therapeutics raised a round of funding on January 08, 2009.

Karus Therapeutics develops medicines that have potential in treating inflammatory disease and cancer. The Company's scientific excellence is reflected in its PI3K and HDAC6 inhibitor programs, from w…

Articles about Karus Therapeutics' Unattributed VC Round: